top of page
  • Contact Us
  • Facebook Social Icon
  • Instagram Social Icon
  • Twitter Social Icon
2026 Keynote SPEAKERS
Monique Carry_edited.jpg

Monique Carry, PhD

Executive Director of the Prevention Access Campaign

Dr. Monique Carry is Executive Director of the Prevention Access Campaign (PAC), where she leads global efforts to expand Undetectable = Untransmittable (U=U) through advocacy, training, and real-world implementation. A behavioral scientist and health communications expert with over 15 years of experience, she previously served at the Centers for Disease Control and Prevention (CDC), supporting U=U scale-up across more than 50 countries. She authored the CDC/PAC U=U implementation resource guide and leads U=U University, equipping communities and health systems with the tools to deliver evidence-based, stigma-free HIV care and build more resilient, informed communities.

Adam Thompson.jpg

Adam Thompson

Practice Facilitator and Implementation Support Practitioner

Mr. Adam Thompson holds an undergraduate degree from  Georgetown University in Theology, a master’s degree in public health from the Jefferson College of Population Health, and a certificate in Practice Facilitation from the University of Buffalo. Adam has served as a coach and faculty on state and national quality improvement learning collaboratives and facilitates multiple regional practice transformation networks supporting Ryan White HIV/AIDS Programs and Federally Qualified Health Centers.

 

Adam has co-developed and facilitated several curricula aimed at improving patient engagement in quality improvement activities, increasing the use of practice facilitation methods amongst capacity-building providers, and increasing the adoption and uptake of implementation science research methods into practice-based settings. He has spoken extensively about the impact of health-related stigmas on patient outcomes, increasing patient engagement and involvement, and health systems redesign.

 

As a person with HIV with a history of injection drug use, commercial sex work, and homelessness, Adam also brings a shared lived experience with many people and communities disproportionately impacted by HIV.

Burley  III_edited_edited.png

Ulysses W. Burley III, MD MPH

Founder of UBtheCURE, LLC

Dr. Ulysses W. Burley III is the founder of UBtheCURE, LLC - a Chicago-based consulting company on the intersection of Faith, Health, and Human Rights with a commitment to ending the HIV/AIDS epidemic as a public health crisis. Although his primary training is in Allergy/Immunology and cancer epidemiology, Ulysses is dedicated to a lifetime of increasing HIV and AIDS awareness and advocacy.

 

Ulysses has served as a member of the Executive Committee of the World Council of Churches as well as the United States Presidential Advisory Council on HIV/AIDS (PACHA) under the Obama Administration. He has been recognized by the National Minority Quality Forum as a top 40 under 40 Minority Health Leader for his work in faith and HIV in communities of color, and is a founding member of the National Faith HIV/AIDS Awareness Day and the U.S. HIV/AIDS Faith Coalition, of which he is Chair.

 

Currently, UBtheCURE leads the HIV Vaccine Trials Network (HVTN) External Relations Research Project, where Ulysses is the Principal Investigator for the HVTN Faith Initiative. The HVTN Faith Initiative is a program designed to connect with diverse faith communities to share evidence-based information regarding HIV and vaccines and antibodies being developed for its prevention.

 

Ulysses is an internationally recognized speaker and award-winning writer on topics including faith, HIV/AIDS policy, COVID-19, LGBTQIA+, gender and racial justice, food security, and peace in Palestine and Israel. His professional mantra is to “treat people and not just disease.”

Gail Bolan
Derek Spencer
Gina Brown

© 2019  The South Carolina HIV, STD and Viral Hepatitis Conference

Annual SC HIV/STD Conference, Inc. is a 501(c)(3) organization. 

EIN 20-3795068

The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the SC Annual HIV/STD Conference, Inc. or its sponsors; nor does mention of trade names, commercial practices, or organizations imply endorsement by the SC Annual HIV/STD Conference, Inc., or its sponsors.

bottom of page